Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
As monotherapy, cagrilintide produced 11.8% weight loss in the Phase 3 REDEFINE 1 trial at 68 weeks with the 2.4 mg dose
Product Name: GHK-Cu Classification: Copper Peptide Complex Structural Description: Tripeptide-copper complex (Glycyl-L-histidyl-L-lysine:copper(II)) CAS Number: 89030-95-5 Molecular Weight: 402.92 g/mol (peptide + copper complex) Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: Lyophilized (freeze-dried) powder Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
Both components are preclinical (animal/in-vitro)
How to Use: Spray once daily in each nostril
It complements BPC-157 for recovery from procedures or injuries involving skin and superficial tissues
